Characteristics and consequences of myocardial infarction after percutaneous coronary intervention: insights from the Coronary Angioplasty Versus Excisional Atherectomy Trial (CAVEAT).

[1]  Thomas J. Ryan,et al.  Guidelines for Percutaneous Transluminal Coronary Angioplasty A Report of the American Heart Association/American College of Cardiology Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Committee on Percutaneous Transluminal Coronary Angioplasty) , 1993, Circulation.

[2]  Craig D. Miller,et al.  Management of Patients With Intramural Hematoma of the Thoracic Aorta , 1993, Circulation.

[3]  A. Jaffe,et al.  Biochemical Markers of Myocardial Injury Is MB Creatine Kinase the Choice for the 1990s? , 1993, Circulation.

[4]  D. Ricci,et al.  A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. , 1993, The New England journal of medicine.

[5]  R. Califf,et al.  A Comparison of Directional Atherectomy with Coronary Angioplasty in Patients with Coronary Artery Disease , 1993 .

[6]  W. Weintraub,et al.  Recent changes in the management and outcome of acute closure after percutaneous transluminal coronary angioplasty. , 1993, The American journal of cardiology.

[7]  R. Shaw,et al.  Coronary rotational ablation: initial experience in 302 procedures. , 1993, Journal of the American College of Cardiology.

[8]  J. Simpson,et al.  Directional coronary atherectomy complications and management. , 1993, Catheterization and cardiovascular diagnosis.

[9]  E L Hannan,et al.  Percutaneous transluminal coronary angioplasty in New York State. Risk factors and outcomes. , 1992, JAMA.

[10]  P. Serruys,et al.  Abrupt coronary artery occlusion during percutaneous transluminal coronary angioplasty. , 1992, American heart journal.

[11]  E. Topol,et al.  Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. , 1992, Journal of the American College of Cardiology.

[12]  L. Klein,et al.  Incidence and clinical significance of transient creatine kinase elevations and the diagnosis of non-Q wave myocardial infarction associated with coronary angioplasty. , 1991, Journal of the American College of Cardiology.

[13]  E. Gilpin,et al.  Short- and long-term clinical outcome after Q wave and non-Q wave myocardial infarction in a large patient population. , 1989, Circulation.

[14]  R E Vlietstra,et al.  Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. , 1988, Journal of the American College of Cardiology.

[15]  F. Loop,et al.  Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures (Subcommittee on Percutaneous Transluminal Coronary Angioplasty). , 1988, Circulation.

[16]  J. Oh,et al.  Creatine kinase release after successful percutaneous transluminal coronary angioplasty. , 1985, American heart journal.

[17]  R. Califf,et al.  Diagnostic and prognostic significance of minimally elevated creatine kinase-MB in suspected acute myocardial infarction. , 1985, The American journal of cardiology.

[18]  E. Braunwald.  Heart Disease: A Textbook of Cardiovascular Medicine , 1992, Annals of Internal Medicine.

[19]  R. Gorlin,et al.  The myth of acute "mild" myocardial infarction. , 1977, Annals of internal medicine.